Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct;14(10):686-91.
Epub 2012 Oct 30.

Vancomycin-Resistant Entrococci colonization in chronic hemodialysis patients and its risk factors in southern Iran (2005-2006)

S Shaghaghian  1 , B Pourabbas, A Alborzi, M Askarian, J Mardaneh
Affiliations

Vancomycin-Resistant Entrococci colonization in chronic hemodialysis patients and its risk factors in southern Iran (2005-2006)

S Shaghaghian et al. Iran Red Crescent Med J. 2012 Oct.

Abstract

Background: Vancomycin-resistant enterococci (VRE) recently have emerged as a nosocomial pathogen among dialysis patients. This study aims to appraise the prevalence, incidence density and risk factors for VRE colonization among these patients.

Methods: In this prospective study, 782 stool or rectal swab specimens were collected from 250 chronic hemodialysis patients with an interval of at least one month. To identify the risk factors of VRE colonization, demographic and health data of VRE+ and VRE- patients were compared.

Results: VRE colonization was detected in 55 (22%) patients during study. Incidence density of one case per 79.6 patient-month of follow up was estimated.The only significant difference between the data collected from VRE+ and VRE- patients was observed in antibiotic consumption (P<0.001).

Conclusion: VRE colonization is relatively high and rapidly spreading among chronic dialysis patients. It is strongly associated with recently antibiotic consumption.

Keywords: Hemodialysis; Iran; Risk Factor; Vancomycin Resistant Entrococci.

PubMed Disclaimer

References

    1. Berns JS. Infection with antimicrobial-resistant microorganisms in dialysis Patients. Semin Dial. 2003;16(1):30–37. - PubMed
    1. Austin DJ, Bonten MJ, Weinstein RA, Slaughter S, Anderson RM. Vancomycin-resistant enterococci in intensive-care hospital setting: Transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci USA. 1999;96:6908–13. - PMC - PubMed
    1. Tokars JI, Gehr T, Jarvis WR, Anderson J, Armistead N, Miller ER, Parrish J, Qaiyumi S, Arduino M, Holt SC, Tenover FC, Westbrook G, Light P. Vancomycin-resistant entrococci colonization in patients at seven hemodialysis Centers. Kidney Int. 2001;60:1511–1516. - PubMed
    1. Axon RN, Engemann JJ, Butcher J, Lockamy K, Kaye KS. Control of nosocomial acquisition of Vancomycin-resistant enterococcus through active surveillance of hemodialysis patients. Infect control Hosp Epidemiol. 2004;25:436–7. - PubMed
    1. Fishbane S, Cunha BA, Mittal SK, Ruggian J, Shea K, Schoch PE. Vancomycin-resistant entrococci in hemodialysis patients is related to intravenous vancomycin use. Infect Control Hosp Epidemiol. 1999;20:461–2. - PubMed